Spots Global Cancer Trial Database for gemtuzumab ozogamicin 1
Every month we try and update this database with for gemtuzumab ozogamicin 1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia) | NCT04093505 | Acute Myeloid L... | Gemtuzumab Ozog... Gemtuzumab Ozog... Glasdegib Placebo Oral Ta... | 60 Years - | University Hospital Heidelberg | |
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia) | NCT04093505 | Acute Myeloid L... | Gemtuzumab Ozog... Gemtuzumab Ozog... Glasdegib Placebo Oral Ta... | 60 Years - | University Hospital Heidelberg |